z-logo
open-access-imgOpen Access
Plasma Exchange in Severe Attacks of Neuromyelitis Optica
Author(s) -
Mickaël Bonnan,
Philippe Cabre
Publication year - 2012
Publication title -
multiple sclerosis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 6
eISSN - 2090-2662
pISSN - 2090-2654
DOI - 10.1155/2012/787630
Subject(s) - neuromyelitis optica , medicine , optic neuritis , myelitis , multiple sclerosis , transverse myelitis , clinical trial , window of opportunity , neuroscience , pediatrics , immunology , pathology , spinal cord , psychiatry , psychology , computer science , real time computing
Background . Neuromyelitis optica (NMO) attacks are poorly controlled by steroids and evolve in stepwise neurological impairments. Assuming the strong humoral response underlying NMO attacks, plasma exchange (PLEX) is an appropriate technique in severe NMO attacks. Objective . Presenting an up-to-date review of the literature of PLEX in NMO. Methods . We summarize the rationale of PLEX in relation with the physiology of NMO, the main technical aspects, and the available studies. Results . PLEX in severe attacks from myelitis or optic neuritis are associated with a better outcome, depending on PLEX delay (“time is cord and eyes”). NMO-IgG status has no influence. Finally, we build up an original concept linking the inner dynamic of the lesion, the timing of PLEX onset and the expected clinical results. Conclusion . PLEX is a safe and efficient add-on therapy in NMO, in synergy with steroids. Large therapeutic trials are required to definitely assess the procedure and define the time opportunity window.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom